Efficacy of Intramuscular Naloxone 0.4mg. in Prophylaxis of Intrathecal Morphine Induced Pruritus After Cesarean Section

Morphine Adverse Reaction Clinical Trial

Official title:
Efficacy of Intramuscular Naloxone 0.4mg. in Prophylaxis of Intrathecal

Status Completed

Clinical Trial Summary

The purpose of this study is to determine whether intramuscular naloxone 0.4mg. is effective in prophylaxis of intrathecal morphine induced pruritus after cesarean section.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

Morphine Adverse Reaction

Clinical Trial Details

NCT number	NCT00890942
Study type	Interventional
Source	Mahidol University
Contact
Status	Completed
Phase	N/A
Start date	May 2009
Completion date	May 2010

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04052867` - Intravenous Lignocaine Infusion in Laparoscopic Donor Nephrectomy	N/A
Not yet recruiting	`NCT05560542` - Intrathecal Dexamethasone and Atropine on Morphine Induced Post-operative Nausea and Vomiting on Caesarean Section	N/A
Terminated	`NCT01844206` - Two Dose Epidural Morphine for Post-cesarean Analgesia	Phase 4
Completed	`NCT03035942` - Quality of Recovery After Dexamethasone, Ondansetron or Placebo Intrathecal Morphine Administration	Phase 4
Completed	`NCT01952626` - Prevention of Intrathecal Morphine Induced Pruritus: Comparison of Ondansetron and Palonosetron	N/A